Cargando…
Development of functional nanomedicines for tumor associated macrophages-focused cancer immunotherapy
Clinical cancer immunotherapies are usually impeded by tumor immunosuppression driven by tumor associated macrophages (TAMs). Thus, TAMs can be considered as a promising therapeutic target for improved immunotherapy, and TAMs-focused molecular targeting agents have made ideal progress in clinical pr...
Autores principales: | Wei, Xiao, Wang, Jing, Liang, Min, Song, Mingzhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706587/ https://www.ncbi.nlm.nih.gov/pubmed/36451865 http://dx.doi.org/10.7150/thno.78572 |
Ejemplares similares
-
Anti-Cancer Nanomedicines: A Revolution of Tumor Immunotherapy
por: Li, Wei, et al.
Publicado: (2020) -
Tumor Metabolism-Rewriting
Nanomedicines for Cancer
Immunotherapy
por: Dong, Xiao, et al.
Publicado: (2023) -
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
por: Peng, Shaojun, et al.
Publicado: (2021) -
Activation of cancer immunotherapy by nanomedicine
por: Wang, Lijuan, et al.
Publicado: (2022) -
Nanomedicine and cancer immunotherapy
por: Yu, Hai-jun, et al.
Publicado: (2020)